| 000 | 05375nam a2200397 i 4500 | ||
|---|---|---|---|
| 999 |
_c393681 _d393681 _x1 |
||
| 001 | 393681 | ||
| 003 | ES-MaUEC | ||
| 005 | 20240314174417.0 | ||
| 006 | a|||| o|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 120810s2012 xxua o |||| 0|eng d | ||
| 020 | _a9781617799686 | ||
| 024 | 7 |
_a10.1007/978-1-61779-968-6 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aQR186.7 _b2012 EB |
|
| 245 | 0 | 0 |
_aSingle Domain Antibodies : _bMethods and Protocols _cedited by Dirk Saerens, Serge Muyldermans |
| 250 | _a1st edition 2012 | ||
| 264 | 1 |
_aTotowa, NJ _bHumana Press _c2012 |
|
| 300 |
_a1 recurso en línea (XV, 580 páginas) _b89 ilustraciones, 35 ilustraciones a color |
||
| 336 |
_atexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_aarchivo de texto _bPDF |
||
| 490 | 0 |
_aMethods in Molecular Biology _x1940-6029 _v911 |
|
| 505 | 0 | _aFrom Whole Monoclonal Antibodies to Single Domain Antibodies: Think Small -- Introduction to Heavy Chain Antibodies and Derived Nanobodies -- Overview and Discovery of IgNARs and Generation of VNARs -- Creation of the Large and Highly Functional Synthetic Repertoire of Human VH and Vκ Domain Antibodies -- Preparation of a Naïve Library of Camelid Single Domain Antibodies -- Selection by Phage Display of Single Domain Antibodies Specific to Antigens in Their Native Conformation -- Semi-Automated Panning of Naive Camelidae Libraries and Selection of Single-Domain Antibodies Against Peptide Antigens -- Pichia Surface Display: A Tool for Screening Single Domain Antibodies -- Bacterial Two Hybrid: A Versatile One-Step Intracellular Selection Method -- Intracellular Antibody Capture (IAC) Methods for Single Domain Antibodies -- Selection of Functional Single Domain Antibody Fragments for Interfering with Protein-Protein Interactions Inside Cells: A "One Plasmid" Mammalian Two-Hybrid System -- Cell-Free Selection of Domain Antibodies by In Vitro Compartmentalization -- Selection of VHHs Under Application Conditions -- Isolation and Characterization of Clostridium difficile Toxin-Specific Single-Domain Antibodies -- Selection of VHH Antibody Fragments that Recognize Different Aβ Depositions Using Complex Immune Libraries -- Expression of Single-Domain Antibodies in Bacterial Systems -- Expression of VHHs in S. cerevisiae -- Stable Expression of Chimeric Heavy Chain Antibodies in CHO Cells -- Production of Camel-Like Antibodies in Plants -- Selecting and Purifying Autonomous Human Variable Heavy (VH) Domains -- Solubility and Stability Engineering of Human VH Domains -- Improvement of Proteolytic Stability through In Silico Engineering -- Selection of Human VH Single Domains with Improved Biophysical Properties by Phage Display -- Improvement of Single Domain Antibody Stability by Disulfide Bond Introduction -- Characterization of Single-Domain Antibodies with an Engineered Disulfide Bond -- Affinity Maturation of Single-Domain Antibodies by Yeast Surface Display -- Multivalent Display of Single-Domain Antibodies -- Methods for Determining the PK Parameters of AlbudAbs and of Long Serum Half Life Drugs Made Using the AlbudAb Technology -- Fluorescent Protein Specific Nanotraps to Study Protein-Protein Interactions and Histone-Tail Peptide Binding -- Site-Specific Labeling of His-Tagged Nanobodies with 99mTc: A Practical Guide -- Nanobody-Based Chromatin Immunoprecipitation -- User-Friendly Expression Plasmids Enable the Fusion of VHHs to Application-Specific Tags -- Application of Single Domain Antibodies in Tumor Histochemistry -- Nanobodies as Structural Probes of Protein Misfolding and Fibril Formation -- Molecular Imaging Using Nanobodies: A Case Study -- Case Study on Live Cell Apoptosis-Assay Using Lamin-Chromobody Cell-Lines for High-Content Analysis. | |
| 520 | _aThe development of the hybridoma technology created the possibility to obtain unlimited amounts of monoclonal antibodies (mAb) with high specificity and affinity for any target and to introduce mAbs in a wide range of applications; however, the bulky size of mAbs, costly production, and cumbersome engineering hampered regularly their streamlined development in some applications. In Single Domain Antibodies: Methods and Protocols, expert researchers examine single variable domain antibody fragments, referred to as VH, VL, VHH or VNAR. These fragments are the smallest intact antigen-binding fragments that can be produced recombinantly at low cost. Written in the highly successful Methods in Molecular Biology™ series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. | ||
| 988 | _aSpringer_Protocols_2012 | ||
| 650 | 7 |
_2embne _9143641 _aInmunoglobulinas _vManuales de laboratorio |
|
| 776 | 0 | 8 |
_iPrinted edition: _z9781617799679 |
| 776 | 0 | 8 |
_iPrinted edition: _z9781617799693 |
| 776 | 0 | 8 |
_iPrinted edition: _z9781493959150 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-61779-968-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b01/2024 _dz _eb _zSI |
||